Brazil Prepares COVID-19 Vaccine Importation

Brazil's Anvisa announced on January 2, 2021, that it had approved a request for the exceptional import of 2 million doses on the experimental AZD1222 vaccine by Fiocruz. On December 31, 2020, the approval took place the same day that Fiocruz filed the import order. As the AstraZeneca - Oxford University developed vaccine has not yet been approved in Brazil, entry into the country must follow certain conditions, established by Anvisa.

Previously, AstraZeneca announced the UK Medicines and Healthcare products Regulatory Agency had provided authorization for an emergency supply of COVID-19 Vaccine on December 30, 2020.

And, Serum Institute of India stated it has stockpiled 75 million doses of this COVID-19 vaccine (CoviShield) and will be increasing it to 100 million doses by the first week of January 2020.